1.
Kiran DMD, Vakharia DM, Pawaskar LJ, Sheikh SN. Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study. ijirms [Internet]. 2019 Jan. 12 [cited 2024 Dec. 16];4(01):16 to 20. Available from: https://ijirms.in/index.php/ijirms/article/view/538